(HR) Healthcare Realty Trust - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4219461047
HR EPS (Earnings per Share)
HR Revenue
HR: Medical, Outpatient, Buildings, Clinics, Offices
Healthcare Realty Trust Incorporated (NYSE Realty Trust) is a prominent real estate investment trust (REIT) focused on acquiring, developing, and managing healthcare-related outpatient facilities, primarily situated near leading medical institutions. By strategically expanding its portfolio through targeted property acquisitions and development projects, the company maintains its position as the largest REIT specializing in medical outpatient buildings.
overview> Ticker Symbol is not applicable, instead, the company is identified by the ticker symbol HR on the NYSE, the type is a Real Estate Investment Trust ( (REIT), the Country of origin is the United States, and it falls under the Health Care REITs subcategory within the GICS classification.The companys extensive portfolio comprises around 650 properties, spanning over 8 million square feet,, across 21 states, with a significant presence in key growth markets. This diversified footprint enables Healthcare Realty to capitalize on emerging trends and opportunities in the healthcare sector sector. With a strong emphasis on quality and location, the companys properties are designed to meet the evolving needs of healthcare providers and patients alike.
Looking ahead, based on historical trends and industry outlook, it is forecasted that Healthcare Realty will continue to experience steady growth, driven driven by the increasing demand for outpatient services and the need for modern, efficient healthcare facilities. As the healthcare landscape continues to shift, the companys focus on adaptable, patient-centric facilities is expected to drive long-term value creation. The forecast suggests that the companys strategic initiatives will yield positive results, supported by a recovering economy and a robust healthcare market.
Additional Sources for HR Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
HR Stock Overview
Market Cap in USD | 5,305m |
Sector | Real Estate |
Industry | REIT - Healthcare Facilities |
GiC Sub-Industry | Health Care REITs |
IPO / Inception | 1993-05-26 |
HR Stock Ratings
Growth Rating | -33.2 |
Fundamental | 8.33 |
Dividend Rating | 58.7 |
Rel. Strength | -9.83 |
Analysts | 3 of 5 |
Fair Price Momentum | 15.06 USD |
Fair Price DCF | 12.55 USD |
HR Dividends
Dividend Yield 12m | 7.88% |
Yield on Cost 5y | 7.35% |
Annual Growth 5y | 0.66% |
Payout Consistency | 83.7% |
Payout Ratio | 251.5% |
HR Growth Ratios
Growth Correlation 3m | -75.9% |
Growth Correlation 12m | -56.9% |
Growth Correlation 5y | -52.2% |
CAGR 5y | -2.09% |
CAGR/Max DD 5y | -0.05 |
Sharpe Ratio 12m | -0.18 |
Alpha | -4.76 |
Beta | 0.386 |
Volatility | 26.38% |
Current Volume | 6452.7k |
Average Volume 20d | 2718.6k |
As of June 21, 2025, the stock is trading at USD 15.18 with a total of 6,452,713 shares traded.
Over the past week, the price has changed by +1.61%, over one month by +1.40%, over three months by -7.45% and over the past year by +1.69%.
Neither. Based on ValueRay´s Fundamental Analyses, Healthcare Realty Trust is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 8.33 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of HR is around 15.06 USD . This means that HR is currently overvalued and has a potential downside of -0.79%.
Healthcare Realty Trust has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold HR.
- Strong Buy: 1
- Buy: 0
- Hold: 9
- Sell: 0
- Strong Sell: 1
According to our own proprietary Forecast Model, HR Healthcare Realty Trust will be worth about 16.3 in June 2026. The stock is currently trading at 15.18. This means that the stock has a potential upside of +7.18%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 16.8 | 10.5% |
Analysts Target Price | 17.2 | 13.4% |
ValueRay Target Price | 16.3 | 7.2% |